title: Femtosecond laser-assisted cataract surgery.
abstract: OBJECTIVE
  In 2010, the US Food and Drug Administration (FDA) cleared femtosecond laser systems for cataract surgery. Available in 2011, this technology has the potential to significantly impact cataract surgery.
  
  
  RESULTS
  Femtosecond lasers offer surgeons the ability to make very precise cuts in a targeted area without damaging the surrounding tissues. This technology has already dramatically changed refractive surgery and is poised to do the same for cataract surgery. Three companies, OptiMedica, LenSx (acquired by Alcon in September 2010), and LensAR, in different stages of FDA clearance, are developing femtosecond laser systems for cataract surgery. These systems will create the initial corneal incisions, capsulotomy, and also fragment the lens.
  
  
  CONCLUSIONS
  This article outlines the advantages of femtosecond laser cataract surgery and provides an initial comparison of the LensAR, LenSx/Alcon, and OptiMedica systems and early clinical results.
authors.affiliation: Department of Ophthalmology, Stanford University, Stanford, CA, USA.
authors.forename: Lingmin
authors.initials: L
authors.lastname: He
authors.forename: Katrina
authors.initials: K
authors.lastname: Sheehy
authors.forename: William
authors.initials: W
authors.lastname: Culbertson
mesh_terms: D057866:Anterior Capsule of the Lens / Q000473:pathology / Q000601:surgery*; D002387:Cataract Extraction; D018795:Device Approval; D006801:Humans; D053685:Laser Therapy; D019654:Lens Implantation, Intraocular; D041623:Tomography, Optical Coherence; D014481:United States; D014486:United States Food and Drug Administration